THE CELLULAR TRAFFICKING AND TARGETING OF ANGIOTENSIN-CONVERTING-ENZYME-2 (ACE2) AND NEUTRAL-AMINO-ACID-TRANSPORTER (B0AT1) VARIANTS: IMPLICATIONS FOR THE PATHOGENESIS OF ASSOCIATED DISEASES AND THERAPY